Source: Journal of the American Society of Nephrology. Conference titles: ASN Renal Week. Unidade: FM
Subjects: TRANSPLANTE DE RIM, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, David J. B. et al. Anti-CD20 (rituximab) in higly sensitized patients: an attemp to reduce panel reactive antibody. Journal of the American Society of Nephrology. Washington: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2002APA
Machado, D. J. B., Paula, F. J., Monteiro, F. A. S., Rodrigues, H., Viggiani, C. S., Panajotopoulos, N., & Kalil, J. (2002). Anti-CD20 (rituximab) in higly sensitized patients: an attemp to reduce panel reactive antibody. Journal of the American Society of Nephrology. Washington: Faculdade de Medicina, Universidade de São Paulo.NLM
Machado DJB, Paula FJ, Monteiro FAS, Rodrigues H, Viggiani CS, Panajotopoulos N, Kalil J. Anti-CD20 (rituximab) in higly sensitized patients: an attemp to reduce panel reactive antibody. Journal of the American Society of Nephrology. 2002 ; 13 560A.[citado 2024 nov. 04 ]Vancouver
Machado DJB, Paula FJ, Monteiro FAS, Rodrigues H, Viggiani CS, Panajotopoulos N, Kalil J. Anti-CD20 (rituximab) in higly sensitized patients: an attemp to reduce panel reactive antibody. Journal of the American Society of Nephrology. 2002 ; 13 560A.[citado 2024 nov. 04 ]
